The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
Abstract
In addition to pathology in the gray matter, there are also abnormalities in the white matter in Alzheimer's disease (AD). Sulfatide species are a class of myelin‐specific sphingolipids and are involved in certain diseases of the central nervous system. To assess whether sulfatide content in gray and white matter in human subjects is associated with both the presence of Alzheimer's disease (AD) pathology as well as the stage of dementia, we analyzed the sulfatide content of brain tissue lipid extracts by electrospray ionization mass spectrometry from 22 subjects whose cognitive status at time of death varied from no dementia to very severe dementia. All subjects with dementia had AD pathology. The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age‐matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post‐mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three‐fold in white matter and peaked at the stage of very mild dementia. The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, previous studies have shown that the lipids that were or tended to be decreased in PLCG2 KO mice (cerebrosides, sulfatides and plasmalogens) have been also reported to be decreased early in AD (39–41).”
From Multi-omics analyses reveal novel effects of PLCγ2 deficiency in the mouse brain (2023) · cites this paper as [39]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationFunctions of Ceramide in Coordinating Cellular Responses to Stress
Hannun, Y. A. (1996) · Science · doi:10.1126/science.274.5294.1855 · Cited by 1,612
A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 879
REGULATION OF CERAMIDE PRODUCTION AND APOPTOSIS
Kolesnick, R., & Krönke, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.643 · Cited by 803
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Self-citationSphingolipids—The Enigmatic Lipid Class: Biochemistry, Physiology, and Pathophysiology
Merrill, A. H., Schmelz, E.-M., Dillehay, D. L., Spiegel, S., Shayman, J. A., Schroeder, J. J., Riley, R. T., Voss, K. A., & Wang, E. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.8029 · Cited by 643
Coetzee, T., Fujita, N., Dupree, J. L., Shi, R., Blight, A. R., Suzuki, K., Suzuki, K., & Popko, B. (1996) · Cell · doi:10.1016/s0092-8674(00)80093-8 · Cited by 624
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 611
Morris, J. C., Storandt, M., McKeel, D. W., Rubin, E. H., Price, J. L., Grant, E. A., & Berg, L. (1996) · Neurology · doi:10.1212/wnl.46.3.707 · Cited by 603
Self-citationHan, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 571
Self-citationPIKE, L. J., Han, X., Chung, K.-N., & Gross, R. W. (2002) · Biochemistry · doi:10.1021/bi0156557 · Cited by 512
Self-citationCell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Węgiel, J., Bobinski, M., Jellinger, K. A., & Wísniewski, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 464
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H. S., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 440
Han, X., & Gross, R. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10635 · Cited by 436
Self-citationHan, X., & Gross, R. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5178 · Cited by 358
Self-citationBosio, A., Binczek, E., & Stoffel, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13280 · Cited by 347
Svennerholm, L. T., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 327
The Role of Oxidative Stress in Alzheimer Disease
Markesbery, W. R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1449 · Cited by 312
Han, X., & Gross, R. W. (1995) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(95)00568-4 · Cited by 290
Self-citationChemistry and functional distribution of sulfoglycolipids
Ishizuka, I. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00011-8 · Cited by 289
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase
Marathe, S. V., Schissel, S. L., Yellin, M. J., Beatini, N., Mintzer, R., Williams, K. J., & Tabas, I. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4081 · Cited by 273
Ceramide Interaction with the Respiratory Chain of Heart Mitochondria
Di Paola, M., Cocco, T., & Lorusso, M. (2000) · Biochemistry · doi:10.1021/bi9924415 · Cited by 262
Magnetic resonance spectroscopy in AD
Valenzuela, M., & Sachdev, P. S. (2001) · Neurology · doi:10.1212/wnl.56.5.592 · Cited by 256
Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
Mattson, M. P., Barger, S. W., Furukawa, K., Bruce‐Keller, A. J., Wyss‐Coray, T., Mark, R. J., & Mucke, L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00014-8 · Cited by 243
Metabolic and functional aspects of sulfogalactolipids
Vos, J. P., Lopes‐Cardozo, M., & Gadella, B. M. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90262-3 · Cited by 224
Inflammation of the brain in Alzheimer's disease: implications for therapy
McGeer, P. L., & McGeer, E. G. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.4.409 · Cited by 217
Neuropathology of white matter changes in Alzheimer’s disease and vascular dementia
Englund, E. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051183 · Cited by 213
Brann, A. B., Scott, R., Neuberger, Y., Abulafia, D. P., Boldin, S. A., Fainzilber, M., & Futerman, A. H. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08199.1999 · Cited by 194
Xu, J., Yeh, C.-H., Chen, S., He, L., Sensi, S. L., Canzoniero, L. M. T., Choi, D. W., & Hsu, C. Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.16521 · Cited by 183
Han, X. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5536 · Cited by 180
Self-citationAging, Metabolism, and Alzheimer Disease: Review and Hypotheses
Finch, C. E., & Cohen, D. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6339 · Cited by 146
Hsu, F., & TURK, J. W. (2001) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(00)00194-x · Cited by 146
Neural membrane phospholipids in alzheimer disease
Wells, K., Farooqui, A., Liss, L., & Horrocks, L. (1995) · Neurochemical Research · doi:10.1007/bf00992508 · Cited by 139
Han, X., Gubitosi‐Klug, R., Collins, B. J., & Gross, R. W. (1996) · Biochemistry · doi:10.1021/bi952927v · Cited by 135
Self-citationDiabetes-induced changes in specific lipid molecular species in rat myocardium
Han, X., Abendschein, D. R., Kelley, J., & Gross, R. W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520079 · Cited by 128
Self-citationCerebellar atrophy in Alzheimer's disease—clinicopathological correlations
Węgiel, J., Wı́sniewski, H. M., Dziewíatkowski, J., Badmajew, E., Tarnawski, M. J., Reisberg, ., Mlodzik, B., de Leon, M. J., & Miller, D. C. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01279-7 · Cited by 127
Modulation of cell signalling by ceramides
Gómez‐Muñoz, A. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00201-4 · Cited by 120
Electrospray ionization tandem mass spectrometric analysis of sulfatide.
Hsu, F., Bohrer, A., & TURK, J. W. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00034-4 · Cited by 114
Alzheimer’s Disease and the Cerebellum: A Morphologic Study on Neuronal and Glial Changes
Sjöbeck, M., & Englund, E. M. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051260 · Cited by 105
Cerebrovascular Pathology in Alzheimer's Disease and Leukoaraiosis
Brown, W. R., Moody, D. M., Thore, C. R., & Challa, V. R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06348.x · Cited by 102
Stout, J. C., Jernigan, T. L., Archibald, S. L., & Salmon, D. P. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550080056013 · Cited by 101
Galactosphingolipids and axono-glial interaction in myelin of the central nervous system
Bosio, A., Büssow, H., Adam, J., & Stoffel, W. (1998) · Cell and Tissue Research · doi:10.1007/s004410051051 · Cited by 81
de Chaves, E. I. P., Bussière, M., Vance, D. E., Campenot, R. B., & Vance, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.3028 · Cited by 78
Contribution of neuroimaging in the diagnosis of Alzheimerʼs disease and other dementias
Scheltens, P., & Korf, E. S. C. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00005 · Cited by 72
Burow, M. E., Weldon, C. B., Collins‐Burow, B. M., Ramsey, N. W., McKee, A. S., Klippel, A., McLachlan, J. A., Clejan, S., & Beckman, B. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9628 · Cited by 63
Majocha, R. E., Jungalwala, F. B., Rodenrys, A., & Marotta, C. A. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11798.x · Cited by 52
Purification and activation of brain sulfotransferase.
Sundaram, K., & Lev, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35942-8 · Cited by 37
Chou, D. K. H., & Jungalwala, F. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54154-5 · Cited by 35
Maturation-dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats
Grinspan, J. B., Coulalaglou, M., Beesley, J., Carpio, D. F., & Scherer, S. S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 33
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Węgiel, J., Bobinski, M., Jellinger, K. A., & Wı́sniewski, H. M. (1994) · Acta Neuropathologica · doi:10.1007/s004010050213 · Cited by 32
Mattson, M. P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01114-4 · Cited by 30
Selective silver impregnation of senile plaques: a method useful for computer imaging
Hedreen, J. C., Raskin, L. S., Struble, R. G., & Price, D. L. (1988) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(88)90153-7 · Cited by 18
Sakac, D., & Lingwood, C. A. (1989) · Biochemical Journal · doi:10.1042/bj2610423 · Cited by 11
Research works printed but not linked: 5
- 10.1139/y59-099 · DOI · Paper page
- 10.1042/bj3520079 · DOI
- Kolodny E. H., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2693
- Mattson M. P., 1997, Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease, Trends Neurosci., 20, 373
- Suzuki K., 1995, The Metabolic and Molecular Bases of Inherited Diseases, 2671
Cited by
Sorted by citations
Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126
Self-citationAge-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
Han, X., & Gross, R. W. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300004-jlr200 · Cited by 914
Self-citationRoberts, L. D., Souza, A. L., Gerszten, R. E., & Clish, C. B. (2012) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb3002s98 · Cited by 762
Metabolomics: A Global Biochemical Approach to Drug Response and Disease
Kaddurah‐Daouk, R., Kristal, B. S., & Weinshilboum, R. M. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094715 · Cited by 685
Metadata
- Authors
- Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Han, Xianlin
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 82
- Issue
- 4
- Pages
- 809-818
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1594975246
- Cited by
- 626
- References
- 56
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 29 · 2023: 32 · 2022: 32 · 2021: 29 · 2020: 32 · 2019: 22 · 2018: 29 · 2017: 33 · 2016: 34 · 2015: 24 · 2014: 33 · 2013: 33 · 2012: 36
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p41rr000954-34)
- National Institute on Aging (P 50 AG05681, P50AG005681, P01 AG0 3991, P01AG003991)
- National Center for Research Resources (P41RR00954-240043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, sulfatide, ceramide, white matter, gray matter, brain lipid composition, pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Chemistry, Ceramides, Dementia, Galactosylceramides, Humans, Neuropsychological Tests, Severity of Illness Index, Sphingomyelins, Sulfoglycosphingolipids, Sulfotransferases, Disease Progression, Spectrometry, Mass, Electrospray Ionization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
